Veradigm | MDRX - PE Price to Earnings


Veradigm reported 11.15 in PE Price to Earnings for its fiscal quarter ending in September of 2022.





Pe Change Date
Alcidion 34.43 41.33 Dec/2025
Ambu A/S 38.1 0.53 Mar/2026
Amplifon 23.29 3.5 Mar/2026
Cardinal Health 30.4 5.87 Mar/2026
Centene 14.52 5.86 Jun/2026
Charles River Laboratories 29.26 14.31 Mar/2026
Cigna 11.69 0.34 Jun/2026
Coloplast 28.44 1.25 Dec/2025
Convatec Group 37.13 9.64 Jun/2024
CVS Health 9.65 4.74 Mar/2026
Diasorin 21.19 5 Mar/2026
Elevance Health 17.11 4.71 Jun/2026
General Electric Aerospace 43.09 8.82 Jun/2026
Gulf Medical Proj 16.48 1.98 Dec/2025
Humana 24.28 13.21 Jun/2026
IQVIA Holdings 21.45 2.08 Jun/2026
Laboratory Of America 20.47 5.04 Jun/2026
Maximus 9.54 6.13 Mar/2026
McKesson 23.85 0.07 Dec/2025
Med Life 1.23K 947.04 Mar/2026
Molina Healthcare 86.43 62.64 Jun/2026
Omnicell 42.07 14.85 Jun/2026
Oriola-kd 209.75 148.31 Sep/2024
Owens Minor 120.72 101.99 Sep/2025
Quest Diagnostics 21.23 1.17 Jun/2026
Rede D'or Sao Luiz 13.13 1.7 Mar/2026
Siemens Healthineers 14.62 3.49 Mar/2026
Sonova Holding 25.61 4.39 Jun/2025
Supermax Corporation Bhd 11.24 8.02 Sep/2022
UnitedHealth 20.96 5.68 Jun/2026
Veeva Systems 26.77 9.47 Mar/2026
Veradigm 11.15 4.63 Sep/2022
Xerox 15.1 1.94 Jun/2024